Characterizing emerging companies in computational drug development.
Publication
, Journal Article
Markey, C; Croset, S; Woolley, OR; Buldun, CM; Koch, C; Koller, D; Reker, D
Published in: Nature computational science
February 2024
Computation promises to accelerate, de-risk and optimize drug research and development. An increasing number of companies have entered this space, specializing in the design of new algorithms, computing on proprietary data, and/or development of hardware to improve distinct drug pipeline stages. The large number of such companies and their unique strategies and deals have created a highly complex and competitive industry. We comprehensively analyze the companies in this space to highlight trends and opportunities, identifying highly occupied areas of risk and currently underrepresented niches of high value.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Nature computational science
DOI
EISSN
2662-8457
ISSN
2662-8457
Publication Date
February 2024
Volume
4
Issue
2
Start / End Page
96 / 103
Related Subject Headings
- Drug Industry
- Drug Development
- Algorithms
Citation
APA
Chicago
ICMJE
MLA
NLM
Markey, C., Croset, S., Woolley, O. R., Buldun, C. M., Koch, C., Koller, D., & Reker, D. (2024). Characterizing emerging companies in computational drug development. Nature Computational Science, 4(2), 96–103. https://doi.org/10.1038/s43588-024-00594-8
Markey, Chloe, Samuel Croset, Olivia Ruth Woolley, Can Martin Buldun, Christian Koch, Daniel Koller, and Daniel Reker. “Characterizing emerging companies in computational drug development.” Nature Computational Science 4, no. 2 (February 2024): 96–103. https://doi.org/10.1038/s43588-024-00594-8.
Markey C, Croset S, Woolley OR, Buldun CM, Koch C, Koller D, et al. Characterizing emerging companies in computational drug development. Nature computational science. 2024 Feb;4(2):96–103.
Markey, Chloe, et al. “Characterizing emerging companies in computational drug development.” Nature Computational Science, vol. 4, no. 2, Feb. 2024, pp. 96–103. Epmc, doi:10.1038/s43588-024-00594-8.
Markey C, Croset S, Woolley OR, Buldun CM, Koch C, Koller D, Reker D. Characterizing emerging companies in computational drug development. Nature computational science. 2024 Feb;4(2):96–103.
Published In
Nature computational science
DOI
EISSN
2662-8457
ISSN
2662-8457
Publication Date
February 2024
Volume
4
Issue
2
Start / End Page
96 / 103
Related Subject Headings
- Drug Industry
- Drug Development
- Algorithms